![]() |
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses - Novavax Investor Relations
|
| All times are GMT. The time now is 03:50 PM. |